STX-101

N/A

Report date: 2025/01/26 17:17:02

Base Information

Drug NameSTX-101
Drug Alias NameSTX-100 seriesSTX-101
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionDNA repair inhibitors
TargetsUpdating
Therapy Area/IndicationsHormone-Resistant Prostate NeoplasmsCholangiocarcinomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSynthex Labs
China Registration ClassN/A

Develop Information

Active CompaniesSynthex Labs
Inactive CompaniesN/A
Active IndicationsHormone-Resistant Prostate NeoplasmsCholangiocarcinoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A